(Q34738250)

4 August 2017

title

TNP-470 antiangiogenic therapy for advanced murine neuroblastoma (English)

1 reference

4 August 2017

main subject

angiogenesis inhibitor

1 reference

E Nagabuchi

1

1 reference

4 August 2017

W E VanderKolk

series ordinal

2

1 reference

4 August 2017

Y Une

series ordinal

3

1 reference

4 August 2017

M M Ziegler

series ordinal

4

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Journal of Pediatric Surgery

4 August 2017

published in

1 reference

4 August 2017

volume

32

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

287-293

1 reference

Anti-angiogenesis: new concept for therapy of solid tumors

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Analysis of experimental antiangiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

New chemotherapeutic agents for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Immune-mediated regression of 'metastatic' neuroblastoma in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Systematic analysis of the immunoregulation of murine neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2897%2990196-2

10.1016/S0022-3468(97)90196-2

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference